Quantum BioPharma Ltd. Signs Phase 2 Trial Contract with Thermo Fisher Scientific

Quantum BioPharma Ltd. has signed a contract with Thermo Fisher Scientific's clinical research business to implement a Phase 2 trial for its novel neuroprotective therapy for multiple sclerosis.